CRMD
CorMedix Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.70
−25.46%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 11.56x
- P/E 2027E
- 100.00x
- P/E 2028E
- 12.92x
- P/S forward
- 1.63x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.36x
- PEG TTM
- —
- Price / book
- 0.96x
- Price / sales
- 0.96x
- Price / cash flow
- 1.75x
Enterprise value
- Enterprise value
- $332.4M
- EV / sales
- 0.72x
- EV / EBITDA
- 1.33x
- EV / EBIT
- 1.53x
- Market cap
- $443.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026